Lectures were provided by WDOM faculty and keynote speaker, Dr. Drew Weissman, who played a major role in critical discoveries that allowed for the mRNA platform to be used in developing vaccines against SARS-CoV.
The researchers found that SARS-CoV-2 triggers an inflammatory antiviral response in the adipose tissue (body fat) and causes its dysfunction.
With more than 200 pulmonary disorders that fall under the umbrella of ILD, patient evaluation, proper diagnosis, and determining the best treatment is of the utmost importance.
The Fund for the Future award supports selected junior faculty during the crucial period of career development spanning completion of research training through the early years of their first faculty position at WCM.
IPF develops when the lungs become damaged or scarred, making it difficult to breathe. Researchers have long been searching for a better mechanistic understanding of IPF that could lead to better treatment.
A development program for junior faculty, LAMP provides participants with critical tools to accomplish their primary career goals as academicians in the field of medicine.
In her new role, Dr. Zappetti will be focused on advancing ambulatory programs across the WDOM, working to ensure the best use of space and resources to meet the growing needs of patients at WCM and NYP.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 17.
Until a vaccine is discovered and implemented for COVID-19, WDOM physicians on the frontlines continue to focus on diagnosis, drug treatment options, and best practices.
In response to the COVID-19 pandemic, faculty from across the Weill Department of Medicine have been pursuing critical research.
